Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-22-045017
Filing Date
2022-04-12
Accepted
2022-04-12 14:50:25
Documents
7
Period of Report
2022-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm222535d4_def14a.htm DEF 14A 277716
3 GRAPHIC tm111535d4_def14aimg01.jpg GRAPHIC 2380
4 GRAPHIC tm222535d4_def14aimg03.jpg GRAPHIC 3578
5 GRAPHIC tm222535d4_def14aimg04.jpg GRAPHIC 2263
6 GRAPHIC tm222535d4_def14aimg05.jpg GRAPHIC 4922
7 GRAPHIC tm222535d4_def14aimg06.jpg GRAPHIC 7401
8 GRAPHIC j2225353_aa001.jpg GRAPHIC 6315
  Complete submission text file 0001104659-22-045017.txt   316724
Mailing Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110
Business Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110 6177728515
TEKLA LIFE SCIENCES INVESTORS (Filer) CIK: 0000884121 (see all company filings)

EIN.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
Type: DEF 14A | Act: 34 | File No.: 811-06565 | Film No.: 22821963